Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Canada Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20035
20043
20055
200614
20072
20086
20098
20106
20115
20127
20134
201411
20159
20163
20177
20188
201911
20204
202111
20228
20233
20245
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Terminated29
Active, not recruiting20
Recruiting12
Unknown status4
Not yet recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto15
AstraZeneca10
Novartis Pharmaceuticals9
Eli Lilly and Company8
Bristol-Myers Squibb6
Pfizer6
Hoffmann-La Roche5
National Cancer Institute (NCI)5
British Columbia Cancer Agency4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung162
Lung Neoplasms45
Neoplasms17
Neoplasm Metastasis10
Breast Neoplasms8
Melanoma7
Brain Neoplasms6
Carcinoma6
Colorectal Neoplasms6
Head and Neck Neoplasms6

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.